Imperial Valley News Center
FDA approves first treatment for certain patients with Erdheim-Chester Disease
- Details
- Written by IVPost
Washington, DC - The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood. Zelboraf is indicated to treat patients whose cancer cells have a specific genetic mutation known as BRAF V600. This is the first FDA-approved treatment for ECD.
Limited Resumption of Visa Services in Turkey
- Details
- Written by State Department
Washington, DC - As announced by our Embassy in Ankara this morning, the United States has received initial high-level assurances from the Government of Turkey that there are no additional local employees of our Mission in Turkey under investigation. We have also received initial assurances from the Government of Turkey that local staff of our Embassy and consulates will not be detained or arrested for performing their official duties and that Turkish authorities will inform the U.S. government in advance if the Government of Turkey intends to detain or arrest a member of our local staff in the future.
State animal ID rules aim to assure livestock health
- Details
- Written by CDFA veterinarian Rebecca Campagna
Sacramento, California - The ability to quickly trace movements of sick animals or animals exposed to disease is essential to maintain the health of California’s livestock. Individual animal identification and accurate record keeping are the foundations of animal disease traceability.
Deputy Secretary of State John J. Sullivan at Signing of the Millennium Challenge Corporation (MCC) Compact With the Republic of Côte d'Ivoire
- Details
- Written by State Department
Washington, DC - Deputy Secretary of State John Sullivan and Millennium Challenge Corporation (MCC) Acting CEO Jonathan Nash will welcome President of the Republic of Côte d’Ivoire Alassane Ouattara at the U.S. Department of State for the signing of a new $525 million MCC compact with the Republic of Côte d’Ivoire on Tuesday, November 7, 2017, at 10:00 a.m.
Southern California Auto Dealership Group to Pay $1.4 Million for Violating FTC Order Requiring Clear Financing and Leasing Disclosures
- Details
- Written by IVN
Washington, DC - A Southern California-based auto dealership group will pay $1.4 million to settle Federal Trade Commission charges that it violated a 2014 administrative order prohibiting it from misrepresenting how much consumers could pay to finance or lease a vehicle.
FDA agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
Washington, DC - At a time when people are more aware of and engaged in their health care than ever before, genetic risk testing can provide helpful information about an individual’s predisposition for certain diseases and conditions. These tests can prompt consumers to be more engaged in pursuing the benefits of healthy lifestyle choices and more aware of their health risks. Consumers are increasingly embracing genetic health risk (GHR) testing to better understand their individual risk for developing diseases. This engagement prompts some people to make more informed lifestyle choices.
Page 1683 of 3785